Evaluating monoclonal gammopathies of unknown significance (MGUS) with free light chain assays in clinical practice

Multiple myeloma is a cancer of the plasma cell. Plasma cells are white blood cells that make antibodies that help to protect us from infections. However, the cells grow too much in myeloma, crowding out normal cells in the bone marrow that make red blood cells, platelets, and other white blood cells.

Free light chains (FLC), kappa and lambda, are produced by plasma cells and known to be an important marker in patients with multiple myeloma and AL amyloidosis.

This webinar will review the pathophysiology of multiple myeloma with an emphasis on monoclonal gammopathy of undetermined significance (MGUS). The presentation is designed for laboratorians/clinicians who are interested in learning more about the clinical and laboratory investigation of multiple myeloma and MGUS, and the potential clinical usage of the N Latex FLC assay in evaluation of MGUS.

Key learning objectives

• Define multiple myeloma and MGUS
• Describe the clinical criteria used to define multiple myeloma
• Describe the use of free light chains in the evaluation of MGUS

Who should attend?

Job Titles: Lab Director, Lab Manager, Lab Technician, Chemistry Supervisor, Nephrologist, Oncologist (multiple myeloma), Hematologists, Customers running Freelite® on Atellica® NEPH 630 or BN Systems.

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

Accreditation statement

SelectScience is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. Attendees of this one-hour webinar are also entitled to 1.0 ACCENT Continuing Education Credits from the AACC. This activity was planned in accordance with ACCENT® Standards and Policies. Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email education@aacc.org.